Bezlotoxumab - A new agent for clostridium difficile infection

John Bartlett

doi:10.1056/NEJMe1614726

Bezlotoxumab - A new agent for clostridium difficile infection

John Bartlett

Johns Hopkins Health System

Research output: Contribution to journal › Editorial › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	381-382
Number of pages	2
Journal	New England Journal of Medicine
Volume	376
Issue number	4
DOIs	https://doi.org/10.1056/NEJMe1614726
State	Published - Jan 26 2017

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMe1614726

Cite this

@article{2824cef6e758441ea27de15b81fc3382,

title = "Bezlotoxumab - A new agent for clostridium difficile infection",

author = "John Bartlett",

year = "2017",

month = jan,

day = "26",

doi = "10.1056/NEJMe1614726",

language = "English (US)",

volume = "376",

pages = "381--382",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Bezlotoxumab - A new agent for clostridium difficile infection

AU - Bartlett, John

PY - 2017/1/26

Y1 - 2017/1/26

UR - http://www.scopus.com/inward/record.url?scp=85010953522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010953522&partnerID=8YFLogxK

U2 - 10.1056/NEJMe1614726

DO - 10.1056/NEJMe1614726

M3 - Editorial

C2 - 28121509

AN - SCOPUS:85010953522

SN - 0028-4793

VL - 376

SP - 381

EP - 382

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 4

ER -

Bezlotoxumab - A new agent for clostridium difficile infection

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this